1
/
의
1
AntibodySystem
SKU(재고 관리 코드):DHB65499
Lifastuzumab vedotin (ADC)
Lifastuzumab vedotin (ADC)
Catalog No.: DHB65499
| Catalog No. | DHB65499 |
|---|---|
| Product name | Lifastuzumab vedotin (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Lifastuzumab vedotin is an ADC consisting of a NaPi2b-directed antibody and Monomethyl auristatin E (MMAE) used for the study of non-small cell lung cancer. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | NaPi2b |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | RG7599, DNIB0600A |
| Clone ID | Lifastuzumab vedotin |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
